What's new

Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 23, Status: Authorised

May 5, 2025 - 15:57
 0
Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Spikevax (previously C...

Next Article

Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluti...

Related Posts

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted),selvacovatein,damlecovatein, Date of authorisation: 30/03/2023, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 30, 2025  0

Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Business process description for inspection coordination

Apr 22, 2025  0